Impact of Biophoton Therapy on Patients With Brain Disorders (Alzheimer's) Clinical Study Available to Treat Alzheimer’s Disease, Dementia, Traumatic Brain Injury and Parkinson’s Disease

—an IRB approved clinical study 

 Listed on clinicaltrials.gov (NCT06147999) - click here.

Enrolling patients with brain-related disorders, such as Alzheimer’s disease, Dementia, Traumatic Brain Injury, and Parkinson’s disease: First Institute of All Medicines, a non-profit organization, is conducting a clinical study. This is a double blinded, placebo-controlled randomized clinical study to investigate whether biophoton generators may be able to help to recover brain and body functions. This is an IRB-approved clinical study.

LOCATION:
TESLA BIOHEALING CENTER & WELLNESS HOTEL

World’s First BioEnergy Wellness Hotel
139 Pittsburgh Road
Butler, PA 16001
Telephone: 724-431-0033

Medical research staff of First Institute of All Medicines will be conducting this study using research facilities at the Tesla BioHealing Energized Wellness Center.

Our study participants and their caregiver guests will sleep on a bed powered by biophoton generators.

Study Specifics:

• Participants: A total of 80 volunteers with clinically diagnosed Alzheimer’s disease, Dementia, Traumatic brain injury, and Parkinson’s disease.
• Duration: Each study participant is to complete 4 or 6 weeks living in a hotel-like wellness center; this study is non-invasive. Simply sleep in a Tesla BioHealing Energized room powered with biophoton generators. This study is to start on November 15, 2023, and be completed for all participants on November 15, 2024.
• Procedures: Sleep nightly in a bed with Tesla BioHealing Biophoton Generators underneath (or placebo) and complete life quality and cognitive capacity assessments. Brain disorder status information will be collected non-invasively by medical and clinical research professionals. The study participants initially placed in the Placebo group for 2 weeks will be switched to the Treatment group for 4 weeks after verifying the placebo effects and to be treated for 4 weeks, with a total of 6 weeks.
• Qualification: There will be a qualification process to participate in this study. The study participant is to submit a doctor's diagnosis of Alzheimer’s disease, Dementia, Traumatic brain injury, or Parkinson’s disease. If you are interested in participating, please click the application link below, or use the contact information below to connect with the clinical research team. You are also welcome to reach out to us if you would like more specific information about participation.
• Cost: There is no direct cost to participate. However, the costs of travel and meals are not covered. Caregivers and qualified study participants are to stay at the Tesla BioHealing Wellness Hotel free of charge for the length of the study.
• Apply today: The research team at First Institute of All Medicines/FIAM looks forward to hearing from you. You'll find the secure application link below. Also, feel free to have a family member or caregiver assist with your registration process by using our contact information.

OR

CONTACT:
Jessica Jackson, Clinical Study Coordinator
First Institute of All Medicines
139 Pittsburgh Road, Butler, PA 16001.
Direct Line: 302-922-2486
Email: Jessica.Jackson@FirstAllMed.org
For general questions, please email: Info@FirstAllMed.org

For clinical research information, please visit: www.FirstAllMed.org
For product information, please visit: www.TeslaBioHealing.com